MedWatch

Novo Nordisk veteran takes up CMO position at Danish-Swedish biotech company

Anders Dyhr Toft, who has worked for Novo Nordisk for many years, will step into the role of CMO at SynAct Pharma on Aug. 1.

Synact Pharma CEO Jeppe Øvlesen | Photo: Synact Pharma / PR

On Wednesday, SynAct Pharma appointed Anders Dyhr Toft as its Chief Medical Officer (CMO). This will come into effect on Aug. 1, according to a company press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs